Back
Protagonist Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
PTGX
Protagonist Therapeutics
Last Price:
44.96
Seasonality Move:
11.46%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight selling pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.17 | Buy |
| 20-day SMA: | 44.7 | Sell |
| 50-day SMA: | 45.23 | Sell |
| 200-day SMA: | 35.68 | Buy |
| 8-day EMA: | 41.66 | Sell |
| 20-day EMA: | 43.5 | Sell |
| 50-day EMA: | 43.92 | Sell |
| 200-day EMA: | 36.78 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.43 | Sell |
| Relative Strength Index (14 RSI): | 41.01 | Sell |
| Chaikin Money Flow: | -281616 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.23 - 47.93) | Sell |
| Bollinger Bands (100): | (38.1 - 46.24) | Sell |
Protagonist Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 41.65 while PTGX 8-day simple moving average is 41.17, which is a Buy signal.
- The stock price of PTGX is 41.65 while Protagonist Therapeutics 20-day SMA is 44.70, which makes it a Sell.
- Protagonist Therapeutics 50-day simple moving average is 45.23 while PTGX share price is 41.65, making it a Sell technically.
- PTGX stock price is 41.65 and Protagonist Therapeutics 200-day simple moving average is 35.68, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
33
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a Sell
The current Protagonist Therapeutics [PTGX] share price is $41.65. The Score for PTGX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
2.48B
Price in USD:
41.65
Share Volume:
936.37K
Protagonist Therapeutics 52-Week Range
52-Week High:
48.89
52-Week Low:
16.80
Sell
33
Protagonist Therapeutics (PTGX)
is a Sell
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?
The Protagonist Therapeutics stock price is 41.65 USD today. -
Will PTGX stock go up or go down?
Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protagonist Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is overvalued.
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 41.65 while PTGX 8-day exponential moving average is 41.66, which is a Sell signal.
- The stock price of PTGX is 41.65 while Protagonist Therapeutics 20-day EMA is 43.50, which makes it a Sell.
- Protagonist Therapeutics 50-day exponential moving average is 43.92 while PTGX share price is 41.65, making it a Sell technically.
- PTGX stock price is 41.65 and Protagonist Therapeutics 200-day simple moving average is 36.78, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
- PTGX Moving Average Covergence Divergence (MACD) indicator is -1.43, suggesting Protagonist Therapeutics is a Sell
- Protagonist Therapeutics Relative Strength Index (RSI) is 41.01, which suggest Protagonist Therapeutics is oversold
- The Bollinger Bands (25) for Protagonist Therapeutics is (42.23 - 47.93), which suggest Protagonist Therapeutics is a Sell
- The Bollinger Bands (100) for Protagonist Therapeutics is (38.1 - 46.24), which suggest Protagonist Therapeutics is a Sell
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.